Yanchuang Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 4, 2024	Avistone Pharmaceuticals	$139.7M Series B	Guotou Chuangye, IDG Capital	Jonathan Zhu, Cathay Capital
May 19, 2022	Laekna Therapeutics	$61.0M Series D	CS Capital	Infinity Capital, Worldstar
Mar 1, 2021	EpimAb Biotherapeutics	$120.0M Series C	Tony Rong, Sungwon Song	CVentures, Adrian Cheng, Cormorant Asset Management, Decheng Capital, Hidragon Capital, Hony Capital, Octagon Capital, SDIC Fund, ShangBay Capital, Sherpa Healthcare Partners

Total Raised

N/A

Valuation

N/A